PC c.2623C>T ;(p.H875Y)

Variant ID: 11-66617786-G-A

NM_001040716.1(PC):c.2623C>T;(p.H875Y)

This variant was identified in 30 publications

View GRCh38 version.




Publications:


Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo.

Cancer Drug Resistance (Alhambra, Calif.)
Yehya, Amani A; Ghamlouche, Fatima F; Zahwe, Amin A; Zeid, Yousef Y; Wakimian, Kevork K; Mukherji, Deborah D; Abou-Kheir, Wassim W
Publication Date: 2022

Variant appearance in text: PC: H875Y
PubMed Link: 36176747
Variant Present in the following documents:
  • cdr-5-3-667.pdf
View BVdb publication page



Second generation androgen receptor antagonists and challenges in prostate cancer treatment.

Cell Death & Disease
Chen, Yanhua Y; Zhou, Qianqian Q; Hankey, William W; Fang, Xiaosheng X; Yuan, Fuwen F
Publication Date: 2022-07-21

Variant appearance in text: PC: H875Y
PubMed Link: 35864113
Variant Present in the following documents:
  • 41419_2022_Article_5084.pdf
View BVdb publication page



Identifying Phased Mutations and Complex Rearrangements in Human Prostate Cancer Cell Lines through Linked-Read Whole-Genome Sequencing.

Molecular Cancer Research : Mcr
Pham, Minh-Tam MT; Gupta, Anuj A; Gupta, Harshath H; Vaghasia, Ajay A; Skaist, Alyza A; Garrison, McKinzie A MA; Coulter, Jonathan B JB; Haffner, Michael C MC; Zheng, S Lilly SL; Xu, Jianfeng J; DeStefano Shields, Christina C; Isaacs, William B WB; Wheelan, Sarah J SJ; Nelson, William G WG; Yegnasubramanian, Srinivasan S
Publication Date: 2022-07-06

Variant appearance in text: PC: H875Y
PubMed Link: 35452513
Variant Present in the following documents:
  • mcr-21-0683_supplementary_methods_and_figures_s1-5_suppsf1-5.pdf
View BVdb publication page



Clinical Applications of Liquid Biopsy in Prostate Cancer: From Screening to Predictive Biomarker.

Cancers
Ionescu, Filip F; Zhang, Jingsong J; Wang, Liang L
Publication Date: 2022-03-29

Variant appearance in text: PC: H875Y
PubMed Link: 35406500
Variant Present in the following documents:
  • Main text
  • cancers-14-01728.pdf
View BVdb publication page



Comparative Effectiveness of Abiraterone and Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer in Taiwan.

Frontiers In Oncology
Li, Pei-Yu PY; Lu, Ying-Hao YH; Chen, Chung-Yu CY
Publication Date: 2022

Variant appearance in text: PC: H875Y
PubMed Link: 35330713
Variant Present in the following documents:
  • fonc-12-822375.pdf
View BVdb publication page



Overcoming prostate cancer drug resistance with a novel organosilicon small molecule.

Neoplasia (New York, N.Y.)
Zhao, Rui R; Ma, Xiaowei X; Bai, Lijuan L; Li, Xin X; Mamouni, Kenza K; Yang, Yang Y; Liu, HongYan H; Danaher, Alira A; Cook, Nicholas N; Kucuk, Omer O; Hodges, Robert S RS; Gera, Lajos L; Wu, Daqing D
Publication Date: 2021-12

Variant appearance in text: PC: H875Y
PubMed Link: 34781084
Variant Present in the following documents:
  • main.pdf
View BVdb publication page



Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase.

Ebiomedicine
Lin, Hui-Ming HM; Mak, Blossom B; Yeung, Nicole N; Huynh, Kevin K; Meikle, Thomas G TG; Mellett, Natalie A NA; Kwan, Edmond M EM; Fettke, Heidi H; Tran, Ben B; Davis, Ian D ID; Mahon, Kate L KL; Zhang, Alison A; Stockler, Martin R MR; Briscoe, Karen K; Marx, Gavin G; Crumbaker, Megan M; Stricker, Phillip D PD; Du, Pan P; Yu, Jianjun J; Jia, Shidong S; Scheinberg, Tahlia T; Fitzpatrick, Michael M; Bonnitcha, Paul P; Sullivan, David R DR; Joshua, Anthony M AM; Azad, Arun A AA; Butler, Lisa M LM; Meikle, Peter J PJ; Horvath, Lisa G LG
Publication Date: 2021-10

Variant appearance in text: PC: 2623C>T; His875Tyr
PubMed Link: 34656931
Variant Present in the following documents:
  • mmc1.pdf
View BVdb publication page



The inhibitory effect of melatonin on human prostate cancer.

Cell Communication And Signaling : Ccs
Shen, Dexin D; Ju, Lingao L; Zhou, Fenfang F; Yu, Mengxue M; Ma, Haoli H; Zhang, Yi Y; Liu, Tongzu T; Xiao, Yu Y; Wang, Xinghuan X; Qian, Kaiyu K
Publication Date: 2021-03-15

Variant appearance in text: PC: H875Y
PubMed Link: 33722247
Variant Present in the following documents:
  • 12964_2021_Article_723.pdf
View BVdb publication page



Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer.

Cancers
Devlies, Wout W; Handle, Florian F; Devos, Gaëtan G; Joniau, Steven S; Claessens, Frank F
Publication Date: 2021-02-22

Variant appearance in text: PC: H875Y
PubMed Link: 33671614
Variant Present in the following documents:
  • Main text
  • cancers-13-00915.pdf
View BVdb publication page



New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer.

Cells
Conteduca, Vincenza V; Mosca, Alessandra A; Brighi, Nicole N; de Giorgi, Ugo U; Rescigno, Pasquale P
Publication Date: 2021-01-19

Variant appearance in text: PC: H875Y
PubMed Link: 33478015
Variant Present in the following documents:
  • Main text
  • cells-10-00193.pdf
View BVdb publication page



Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer.

Targeted Oncology
Scott, Lesley J LJ
Publication Date: 2020-12

Variant appearance in text: PC: H875Y
PubMed Link: 33237495
Variant Present in the following documents:
  • Main text
  • 11523_2020_Article_779.pdf
View BVdb publication page



Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer.

Frontiers In Oncology
Obinata, Daisuke D; Lawrence, Mitchell G MG; Takayama, Kenichi K; Choo, Nicholas N; Risbridger, Gail P GP; Takahashi, Satoru S; Inoue, Satoshi S
Publication Date: 2020

Variant appearance in text: PC: H875Y
PubMed Link: 33134178
Variant Present in the following documents:
  • fonc-10-581515.pdf
View BVdb publication page



Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer.

Jco Precision Oncology
Taavitsainen, Sinja S; Annala, Matti M; Ledet, Elisa E; Beja, Kevin K; Miller, Patrick J PJ; Moses, Marcus M; Nykter, Matti M; Chi, Kim N KN; Sartor, Oliver O; Wyatt, Alexander W AW
Publication Date: 2019

Variant appearance in text: PC: H875Y
PubMed Link: 32914020
Variant Present in the following documents:
  • PO.19.00014.pdf
View BVdb publication page



Plasma Androgen Receptor in Prostate Cancer.

Cancers
Conteduca, Vincenza V; Gurioli, Giorgia G; Brighi, Nicole N; Lolli, Cristian C; Schepisi, Giuseppe G; Casadei, Chiara C; Burgio, Salvatore Luca SL; Gargiulo, Stefania S; Ravaglia, Giorgia G; Rossi, Lorena L; Altavilla, Amelia A; Farolfi, Alberto A; Menna, Cecilia C; Colangione, Sarah Pia SP; Pulvirenti, Mario M; Romeo, Antonino A; De Giorgi, Ugo U
Publication Date: 2019-11-04

Variant appearance in text: PC: H875Y
PubMed Link: 31689899
Variant Present in the following documents:
  • cancers-11-01719.pdf
View BVdb publication page



Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Medicines (Basel, Switzerland)
Testa, Ugo U; Castelli, Germana G; Pelosi, Elvira E
Publication Date: 2019-07-30

Variant appearance in text: PC: H875Y
PubMed Link: 31366128
Variant Present in the following documents:
  • Main text
  • medicines-06-00082.pdf
View BVdb publication page



Understanding the impacts of missense mutations on structures and functions of human cancer-related genes: A preliminary computational analysis of the COSMIC Cancer Gene Census.

Plos One
Malhotra, Sony S; Alsulami, Ali F AF; Heiyun, Yang Y; Ochoa, Bernardo Montano BM; Jubb, Harry H; Forbes, Simon S; Blundell, Tom L TL
Publication Date: 2019

Variant appearance in text: PC: H875Y
PubMed Link: 31323058
Variant Present in the following documents:
  • pone.0219935.pdf
View BVdb publication page



Metastatic prostate cancer remains incurable, why?

Asian Journal Of Urology
Dong, Liang L; Zieren, Richard C RC; Xue, Wei W; de Reijke, Theo M TM; Pienta, Kenneth J KJ
Publication Date: 2019-01

Variant appearance in text: PC: H875Y
PubMed Link: 30775246
Variant Present in the following documents:
  • main.pdf
View BVdb publication page



Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test.

Prostate Cancer And Prostatic Diseases
González-Billalabeitia, Enrique E; Conteduca, Vincenza V; Wetterskog, Daniel D; Jayaram, Anuradha A; Attard, Gerhardt G
Publication Date: 2019-05

Variant appearance in text: PC: 2623C>T
PubMed Link: 30413805
Variant Present in the following documents:
  • emss-79467.pdf
View BVdb publication page



Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer.

The Journal Of Clinical Investigation
Sharp, Adam A; Coleman, Ilsa I; Yuan, Wei W; Sprenger, Cynthia C; Dolling, David D; Rodrigues, Daniel Nava DN; Russo, Joshua W JW; Figueiredo, Ines I; Bertan, Claudia C; Seed, George G; Riisnaes, Ruth R; Uo, Takuma T; Neeb, Antje A; Welti, Jonathan J; Morrissey, Colm C; Carreira, Suzanne S; Luo, Jun J; Nelson, Peter S PS; Balk, Steven P SP; True, Lawrence D LD; de Bono, Johann S JS; Plymate, Stephen R SR
Publication Date: 2019-01-02

Variant appearance in text: PC: H875Y
PubMed Link: 30334814
Variant Present in the following documents:
  • Main text
View BVdb publication page



Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges.

Cancers
Kita, Yuki Y; Goto, Takayuki T; Akamatsu, Shusuke S; Yamasaki, Toshinari T; Inoue, Takahiro T; Ogawa, Osamu O; Kobayashi, Takashi T
Publication Date: 2018-09-21

Variant appearance in text: PC: H875Y
PubMed Link: 30248934
Variant Present in the following documents:
  • Main text
  • cancers-10-00345.pdf
View BVdb publication page



Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases.

British Journal Of Cancer
Kallio, Heini M L HML; Hieta, Reija R; Latonen, Leena L; Brofeldt, Anniina A; Annala, Matti M; Kivinummi, Kati K; Tammela, Teuvo L TL; Nykter, Matti M; Isaacs, William B WB; Lilja, Hans G HG; Bova, G Steven GS; Visakorpi, Tapio T
Publication Date: 2018-08

Variant appearance in text: PC: H875Y
PubMed Link: 29988112
Variant Present in the following documents:
  • Main text
  • 41416_2018_Article_172.pdf
View BVdb publication page



Novel galeterone analogs act independently of AR and AR-V7 for the activation of the unfolded protein response and induction of apoptosis in the CWR22Rv1 prostate cancer cell model.

Oncotarget
McCarty, David J DJ; Huang, Weiliang W; Kane, Maureen A MA; Purushottamachar, Puranik P; Gediya, Lalji K LK; Njar, Vincent C O VCO
Publication Date: 2017-10-24

Variant appearance in text: PC: H875Y
PubMed Link: 29179452
Variant Present in the following documents:
  • Main text
  • oncotarget-08-88501.pdf
View BVdb publication page



Clinical relevance of androgen receptor alterations in prostate cancer.

Endocrine Connections
Jernberg, Emma E; Bergh, Anders A; Wikström, Pernilla P
Publication Date: 2017-11

Variant appearance in text: PC: H875Y
PubMed Link: 29030409
Variant Present in the following documents:
  • Main text
View BVdb publication page



Clinical application of a cancer genomic profiling assay to guide precision medicine decisions.

Personalized Medicine
Eifert, Cheryl C; Pantazi, Angeliki A; Sun, Ruobai R; Xu, Jia J; Cingolani, Pablo P; Heyer, Joerg J; Russell, Meaghan M; Lvova, Maria M; Ring, Jennifer J; Tse, Julie Y JY; Lyle, Stephen S; Protopopov, Alexei A
Publication Date: 2017-07

Variant appearance in text: PC: H875Y
PubMed Link: 28890729
Variant Present in the following documents:
  • pme-14-309.pdf
View BVdb publication page



Circulating tumor cells in prostate cancer: Precision diagnosis and therapy.

Oncology Letters
Liu, Weiwei W; Yin, Binbin B; Wang, Xuchu X; Yu, Pan P; Duan, Xiuzhi X; Liu, Chunhua C; Wang, Ben B; Tao, Zhihua Z
Publication Date: 2017-08

Variant appearance in text: PC: H875Y
PubMed Link: 28789337
Variant Present in the following documents:
  • ol-14-02-1223.pdf
View BVdb publication page



Detection fidelity of AR mutations in plasma derived cell-free DNA.

Oncotarget
Goldstein, Alexa A; Toro, Patricia Valda PV; Lee, Justin J; Silberstein, John L JL; Nakazawa, Mary M; Waters, Ian I; Cravero, Karen K; Chu, David D; Cochran, Rory L RL; Kim, Minsoo M; Shinn, Daniel D; Torquato, Samantha S; Hughes, Robert M RM; Pallavajjala, Aparna A; Carducci, Michael A MA; Paller, Channing J CJ; Denmeade, Samuel R SR; Kressel, Bruce B; Trock, Bruce J BJ; Eisenberger, Mario A MA; Antonarakis, Emmanuel S ES; Park, Ben H BH; Hurley, Paula J PJ
Publication Date: 2017-02-28

Variant appearance in text: PC: H875Y
PubMed Link: 28152506
Variant Present in the following documents:
  • oncotarget-08-15651.pdf
View BVdb publication page



Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer.

Oncotarget
Wadosky, Kristine M KM; Koochekpour, Shahriar S
Publication Date: 2016-09-27

Variant appearance in text: PC: H875Y
PubMed Link: 27487144
Variant Present in the following documents:
  • oncotarget-07-64447.pdf
View BVdb publication page



The mutational landscape of lethal castration-resistant prostate cancer.

Nature
Grasso, Catherine S CS; Wu, Yi-Mi YM; Robinson, Dan R DR; Cao, Xuhong X; Dhanasekaran, Saravana M SM; Khan, Amjad P AP; Quist, Michael J MJ; Jing, Xiaojun X; Lonigro, Robert J RJ; Brenner, J Chad JC; Asangani, Irfan A IA; Ateeq, Bushra B; Chun, Sang Y SY; Siddiqui, Javed J; Sam, Lee L; Anstett, Matt M; Mehra, Rohit R; Prensner, John R JR; Palanisamy, Nallasivam N; Ryslik, Gregory A GA; Vandin, Fabio F; Raphael, Benjamin J BJ; Kunju, Lakshmi P LP; Rhodes, Daniel R DR; Pienta, Kenneth J KJ; Chinnaiyan, Arul M AM; Tomlins, Scott A SA
Publication Date: 2012-07-12

Variant appearance in text: PC: H875Y
PubMed Link: 22722839
Variant Present in the following documents:
  • NIHMS368879-supplement-2.xlsx, sheet 4
  • NIHMS368879-supplement-1.pdf
View BVdb publication page